CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes [Phase 1]

Pfizer conducted a multiple-dose Phase 1 study of PF-04937319 in adults with type 2 diabetes; the trial has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2, NIDDM | Phase 1 | Status: COMPLETED | Results posted: 2017-02-01